Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1Michele Maio, Sandra Coral, Luca Sigalotti, et al.
Journal of Cellular Physiology|February 4, 2010
Epigenetically regulated clonal heritability of CTA expression profiles in human melanomaElisabetta Fratta, Luca Sigalotti, Francesca Colizzi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2022
Emerging Role of Immunomonitoring to Predict the Clinical Outcome of Patients With Malignant Pleural Mesothelioma Treated With Radical Radiation TherapyMichela Cangemi, Marcella Montico, Marco Trovo, et al.
Journal of Cellular Physiology|July 28, 2011
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implicationsLuana Calabrò, Luca Sigalotti, Ester Fonsatti, et al.
Cell Death & Disease|May 24, 2020
Loss of Spry1 reduces growth of BRAF<sup>V600</sup>-mutant cutaneous melanoma and improves response to targeted therapyBarbara Montico, Francesca Colizzi, Giorgio Giurato, et al.
Journal of Cellular Physiology|October 28, 2005
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implicationsSandra Coral, Luca Sigalotti, Francesca Colizzi, et al.
Journal of Cellular Physiology|April 27, 2007
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applicationsLuca Sigalotti, Elisabetta Fratta, Sandra Coral, et al.
Clinical Epigenetics|June 3, 2017
Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinomaCarlo Furlan, Jerry Polesel, Luigi Barzan, et al.
Frontiers in Immunology|March 21, 2024
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitorsElena Muraro, Barbara Montico, Benedict Lum, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 14, 2025
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanomaBarbara Montico, Giorgio Giurato, Roberto Guerrieri, et al.
Pageof 3